At a glance
- Originator Jouveinal
- Class Antiallergics; Small molecules
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Allergic rhinitis
Most Recent Events
- 15 Mar 1996 Discontinued-II for Allergic rhinitis in France (Unknown route)